#medicare
Trump Drug Pricing Plan Could Cut $529B: Will Your Costs Drop?
The White House says aligning U.S. drug prices with global rates may slash costs—but experts remain divided. What the $529 Billion Savings Really Means According to White House economists, Trump’s drug pricing strategy—often called the “most favored nation” model—could reduce prescription drug costs by up to $529 billion over 10 years. The idea is simple: Americans s
Trump Drug Pricing Plan Could Cut $529B: Will Your Costs Drop?
The White House says aligning U.S. drug prices with global rates may slash costs—but experts remain divided. What the $529 Billion Savings Really Means According to White House economists, Trump’s drug pricing strategy—often called the “most favored nation” model—could reduce prescription drug costs by up to $529 billion over 10 years. The idea is simple: Americans s
Drug Tariffs May Raise Prescription Costs: What Patients Should Know across U.S
A newly announced policy introducing tariffs on certain imported pharmaceuticals could gradually increase prescription drug costs for patients across the United States. The measure applies primarily to brand-name medications that remain under patent, along with some of their active ingredients, with tariff rates potentially reaching up to 100 percent depending on compliance with pricing or domestic production conditions. While generic medications and biosimilars are currently exclud
Drug Tariffs May Raise Prescription Costs: What Patients Should Know across U.S
A newly announced policy introducing tariffs on certain imported pharmaceuticals could gradually increase prescription drug costs for patients across the United States. The measure applies primarily to brand-name medications that remain under patent, along with some of their active ingredients, with tariff rates potentially reaching up to 100 percent depending on compliance with pricing or domestic production conditions. While generic medications and biosimilars are currently exclud
Trump drug pricing deals seen as limited relief for most U.S. patients
President Donald Trump’s recently announced agreements with pharmaceutical companies are expected to have a limited effect on what most Americans pay for prescription drugs, according to health policy experts who say the scope and structure of the deals leave many patients unaffected. Since Sept. 30, the Trump administration has reached agreements with 14 drugmakers in exchange for relie
Trump drug pricing deals seen as limited relief for most U.S. patients
President Donald Trump’s recently announced agreements with pharmaceutical companies are expected to have a limited effect on what most Americans pay for prescription drugs, according to health policy experts who say the scope and structure of the deals leave many patients unaffected. Since Sept. 30, the Trump administration has reached agreements with 14 drugmakers in exchange for relie
Pharma executive collapses during Trump’s Oval Office event on obesity drug prices
A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his
Pharma executive collapses during Trump’s Oval Office event on obesity drug prices
A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his
CVS to close 16 Oak Street Health clinics as part of nationwide restructuring
CVS Health has announced plans to close 16 Oak Street Health primary care clinics across the United States by the end of February 2026, citing the move as part of a broader effort to strengthen its financial position and long-term sustainability. The closures follow a comprehensive review of the company’s clinic operations and come amid a changing healthcare landscape that has placed significant pressure on medical providers. The decision arrives two years after CVS Health acquire
CVS to close 16 Oak Street Health clinics as part of nationwide restructuring
CVS Health has announced plans to close 16 Oak Street Health primary care clinics across the United States by the end of February 2026, citing the move as part of a broader effort to strengthen its financial position and long-term sustainability. The closures follow a comprehensive review of the company’s clinic operations and come amid a changing healthcare landscape that has placed significant pressure on medical providers. The decision arrives two years after CVS Health acquire
Dietary Supplements Industry Faces Challenges in Washington Despite Celebrity Backing
The dietary supplement industry, a multibillion-dollar market, continues to face challenges in Washington despite support from President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. Although the industry has grown in popularity, it is still waiting for significant policy changes that would make it easier for consumers to buy supplements and allow manufacturers more flexibility in making health claims.
Dietary Supplements Industry Faces Challenges in Washington Despite Celebrity Backing
The dietary supplement industry, a multibillion-dollar market, continues to face challenges in Washington despite support from President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. Although the industry has grown in popularity, it is still waiting for significant policy changes that would make it easier for consumers to buy supplements and allow manufacturers more flexibility in making health claims.
NJ Healthcare Executives Sentenced in $127M Kickback Scheme Involving Fake Brace Prescriptions
Two healthcare executives were sentenced to federal prison for orchestrating a massive medical fraud operation that bilked the U.S. government out of $127 million through a scheme involving unnecessary medical braces and illegal kickbacks. The sentencing took place in federal court in Newark, marking the conclusion of one of the more brazen cases of healthcare fraud in recent years. Eric Karlewicz, 46, of Rockland County, New York, and Nicco Romanowski, 33, of Roswell, Georgia,
NJ Healthcare Executives Sentenced in $127M Kickback Scheme Involving Fake Brace Prescriptions
Two healthcare executives were sentenced to federal prison for orchestrating a massive medical fraud operation that bilked the U.S. government out of $127 million through a scheme involving unnecessary medical braces and illegal kickbacks. The sentencing took place in federal court in Newark, marking the conclusion of one of the more brazen cases of healthcare fraud in recent years. Eric Karlewicz, 46, of Rockland County, New York, and Nicco Romanowski, 33, of Roswell, Georgia,









